- Abstract Number: 2159
Pachymeningitis in Rheumatic Disease
- Abstract Number: 2467
Pain and Anxiety Are Independent Factors Associated to Sleep Impairment in Psoriatic Arthritis: A Multicentric Study in 14 Countries
- Abstract Number: 2604
Pain Chronification and the Important Role of Non-disease Specific Symptoms in Patients with Systemic Sclerosis
- Abstract Number: 2845
Pain Patterns in Idiopathic Inflammatory Myopathy (IIM): Associations with Disease Activity Measures (Muscle Enzymes, Manual Muscle Testing 8), Patient-Reported Quality of Life (HAQ) and Pain Scales (Widespread Pain Index (WPI), Symptom Severity Index (SSI) and Visual Analogue Scale)
- Abstract Number: 628
Pain Perception and Opiate Use Among Patients with Inflammatory Arthritis
- Abstract Number: 153
Palliative Care Curriculum in Rheumatology: Teaching Serious Illness Conversations
- Abstract Number: 301
PANLAR Ultrasound Study Group Recommendations for the Use of Imaging in the Management of Patients with Gout
- Abstract Number: 3
Pannexin-1 KO Mice Are Unresponsive to Tenofovir Induced Bone Loss
- Abstract Number: 1053
Parallel Analysis of Systemic Sclerosis and Keloidal Morphea Skin Biopsies Delineates the Hallmark Profibrotic Gene Expression Profile for Scleroderma in Vivo
- Abstract Number: 2842
Paraoxonase 1 Activity Is Abnormal in Patients with Idiopathic Inflammatory Myopathies and Associates with Poor Disease Control
- Abstract Number: 2241
Parent Perspectives on Addressing Emotional Health for Youth with Juvenile Myositis: A Qualitative Focus Group Study
- Abstract Number: 1921
Parent-Reported Medication Side-Effects and Their Impact on Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- Abstract Number: 2224
Parkinson’s Disease and Risk of Fractures : A Meta Analysis of Cohort Studies
- Abstract Number: 274
Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis
- Abstract Number: 1462
Pathogenesis of Vaginal Dryness in Primary Sjögren’s Syndrome: A Histopathological Case-control Study
- Abstract Number: 2257
Patient and Clinical Characteristics Associated with Increased Willingness to Adopt RA Treatment After an Educational Intervention: An Analysis of the Confident Treatment Decisions for Living with Rheumatoid Arthritis (CONTROL-RA) Trial
- Abstract Number: 2256
Patient Beliefs and Perceptions of Methotrexate for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
- Abstract Number: 2388
Patient Characteristics Associated with Long Term Glucocorticoid Use in a Commercially Insured Incident RA Cohort
- Abstract Number: 1380
Patient Characteristics, Treatment Patterns, and Treatment Persistency in Biologic DMARD-Experienced Rheumatoid Arthritis Patients in a US RA Registry
- Abstract Number: 1350
Patient Disease Trajectories in Baricitinib-2 Mg-Treated Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs
- Abstract Number: 2247
Patient Factors Associated with Willingness to Change Rheumatoid Arthritis Medications
- Abstract Number: 2539
Patient Perception of Benefit and Risks Associated with Hydroxychloroquine Use in Systemic Lupus Erythematosus (SLE)
- Abstract Number: 1196
Patient Preference for an Electronic MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/ Routine Assessment of Patient Index Data), Which Gives Similar Results Compared to a Paper Version
- Abstract Number: 2766
Patient Preferences for Attributes of Treatments for Chronic Pain Associated with Osteoarthritis Pain and Chronic Low Back Pain That Differentiate Nerve-Growth Factor Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Opioids in the United States: A Discrete-Choice Experiment
- Abstract Number: 2151
Patient Reported Outcomes and Factors Predicting Clinical Disease Activity in Patients with Immune-Checkpoint Inhibitor Inflammatory Arthritis
- Abstract Number: 423
Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care – Was PRO Remission Achieved? Results from the EuroSpA Collaboration
- Abstract Number: 1083
Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice – Is PRO Remission Achieved? Results from the EuroSpA Collaboration
- Abstract Number: 1209
Patient-reported Outcome Measures in Systemic Lupus Erythematosus: Use in Clinical Practice – Preliminary Results from the Integrate Project
- Abstract Number: 836
Patient-Reported Outcomes from a Randomised, Open-Label, Parallel-Group Study Evaluating Ixekizumab versus Adalimumab in Patients with PsA Who Are Biologic DMARD Naïve: 24-Week Results
- Abstract Number: 1423
Patient-Reported Outcomes of Abatacept in Combination with MTX in Early, MTX-Naïve, ACPA Positive Patients with RA: 1-Year Results from a Phase IIIb Study
- Abstract Number: 1375
Patient-Reported Outcomes of Upadacitinib versus Adalimumab Use in Patients with Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate: 26-Week Analysis of a Phase 3 Study
- Abstract Number: 1314
Patient-Specific Reference Values for Objective Physical Function Tests: Cross-Sectional Analysis Using Data from the Osteoarthritis Initiative
- Abstract Number: 1842
Patients and Relatives Coping with Inflammatory Arthritis: Impact of Communication, Social Support and Relatives Burden on Patients Perceived Health
- Abstract Number: 648
Patients of African Descent Score Higher on Quality of Life Indices Despite Their Known Disease Severity
- Abstract Number: 680
Patients Who Do Not Fulfill the 2018 EULAR/ACR Criteria for Systemic Lupus Erythematosus Accrue Less Damage: Data from a Multicenter, Multiethnic US Cohort
- Abstract Number: 1286
Patients with Anti-tRNA Synthetase Syndrome Are More Likely to Present to Pulmonary Clinic and Have a Higher Prevalence and Severity of Lung Disease Than Patients with Other Types of Myositis or Systemic Sclerosis
- Abstract Number: 2212
Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA
- Abstract Number: 230
Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study
- Abstract Number: 2313
Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis
- Abstract Number: 2702
Patients’ and Parents’ Perception of Disease and Its Impact on Life in Juvenile Idiopathic Arthritis: Results from Multinational Virtual Focus Groups by the OMERACT JIA Working Group
- Abstract Number: 2260
Patients’ Journeys Through Giant Cell Arteritis: A Qualitative Study
- Abstract Number: 570
Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up of Ankylosing Spondylitis (AS) Patients with a Rheumatologist-patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China
- Abstract Number: 1252
Pattern of Arthropathy in Patients with Cystic Fibrosis
- Abstract Number: 347
Patterns and Clinico-Radiological Correlates of Symptomatic Atlantoaxial Joint Involvement in Patients with Calcium Pyrophosphate Deposition Disease
- Abstract Number: 2795
Patterns of Ambulatory Health Care Utilization and Medication Adherence Among Transition-Age Youth with Systemic Lupus Erythematosus
- Abstract Number: 2712
Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry
- Abstract Number: 1334
Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
- Abstract Number: 689
Patterns of High Disease Activity Status and Outcomes in Systemic Lupus Erythematosus
- Abstract Number: 1119
Patterns of Medication Use for Patients with Sarcoidosis: Data from the ACR’s RISE Registry
- Abstract Number: 348
Patterns of Newer Gout Medication Use in a U.S. Electronic Health Record-Based Registry
- Abstract Number: 1340
Patterns of Sustained Remission and Subsequent DMARD Tapering in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort
- Abstract Number: 1009
PDE4 Inhibition Could Improve Endothelial and Adipose Tissue Dysfunction Associated with Psoriatic Arthritis, Key Processes in Cardiovascular Disease
- Abstract Number: 1750
Pediatric Sjögren Syndrome: A Single-Center Experience
- Abstract Number: 1249
Pelvic Congestion Syndrome, an Uncommon Cause of Osteoarticular Pain
- Abstract Number: 2813
Pentameric, but Not Monomeric C-reactive Protein, Limits the SnRNP-immune Complex Triggered Type I Interferon Response: Implications for Lupus Pathogenesis
- Abstract Number: 1720
Pentoxifylline Gel for Oral Ulcers in Patients with Behçet’s Syndrome
- Abstract Number: 1824
Perceived Stress Independently Associates with Worse Type 2 Symptoms in Systemic Lupus Erythematosus
- Abstract Number: 171
Performance of 2010 ACR/EULAR and 1987 ACR Criteria for Classification of Rheumatoid Arthritis in a Population-based Incidence Cohort, 2010-2014
- Abstract Number: 2640
Performance of Berden’s Classification and ANCA Renal Risk Score for the Prediction of End-Stage Renal Disease in ANCA-associated Vasculitis
- Abstract Number: 1373
Performance of CQR5 vs CQR19 in the Evaluation of Adherence to Tofacitinib in Daily Clinical Practice
- Abstract Number: 401
Performance of EULAR/ACR Classification Criteria for Idiopathic Inflammatory Myopathies in a Real-life Cohort of Adult Patients
- Abstract Number: 677
Performance of Montreal Cognitive Assessment (MoCA) in Screening for Cognitive Impairment in Patients with Lupus Compared to the Neuropsychological Battery
- Abstract Number: 657
Performance of the “Do You Know What I Mean” Questionnaire in the Assessment of Disease Knowledge in Patients with Systemic Lupus Erythematosus
- Abstract Number: 593
Performance of the ASAS Classification Criteria Presenting with Undiagnosed Back Pain: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
- Abstract Number: 678
Performance of the EULAR/ACR 2019 Classification Criteria for Systemic Lupus Erythematosus in Men, Diverse Ethnicities, and Early Disease
- Abstract Number: 400
Performance of the European League Against Rheumatism/American College of Rheumatology Idiopathic Inflammatory Myopathies Classification Criteria in a Myositis Cohort from Argentina
- Abstract Number: 413
Performance of the Patient Reported Outcomes Measurement Information System 29-item Profile in Comparison to the Clinical Disease Activity Index (CDAI) and Routine Assessment of Patient Index Data 3 (RAPID3) in an Australian Rheumatoid Arthritis Cohort
- Abstract Number: 1206
Performance of the Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) Item Profile in a Cohort of Australians with RA, OA and Other Inflammatory Arthritic Conditions
- Abstract Number: 650
Performance of the Proposed American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Lupus Erythematosus in Korean Patients
- Abstract Number: 1803
Performance of the RABBIT Infection Score in a Prospective Multicenter Cohort of Rheumatoid Arthritis Patients from Argentina
- Abstract Number: 536
PERFUSE: A French Prospective/Retrospective Non-interventional Cohort Study of Infliximab-naïve and Transitioned Patients Receiving Infliximab Biosimilar SB2; An Interim Analysis
- Abstract Number: 911
Perfusion in Bone Marrow Lesions Assessed on Dynamic Contrast-enhanced MRI and Its Association with Pain in Knee Osteoarthritis: A Cross-sectional Study
- Abstract Number: 372
Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience
- Abstract Number: 1175
Periarticular Inflammation and Bone Marrow Oedema Are Important in the Evaluation of Enthesitis on MRI in Patients with Peripheral and Axial SpA
- Abstract Number: 2007
Periodontal Pockets as a Potential Source of Circulating TREM-1 and Its Ligand PGLYRP1 in Patients with Rheumatoid Arthritis
- Abstract Number: 1805
Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study
- Abstract Number: 2161
Perioperative Glucocorticoid Management in Patients with Rheumatologic Diseases Undergoing Elective Joint Surgeries
- Abstract Number: 663
Peripheral Blood Toll Like Receptor 7 Expression and Serum Interferon Lambda 1 Levels in Systemic Lupus Erythematosus and Their Relation to Disease Activity and Lupus Nephritis
- Abstract Number: 617
Peripheral Involvement Is Associated with Less Radiographic Spinal Progression in Patients with Early Axial Spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort
- Abstract Number: 671
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
- Abstract Number: 2870
Persistence of B Cell-rich Synovitis Following Conventional Synthetic Disease Modifying Anti-Rheumatic Drug Treatment in Early Rheumatoid Arthritis Is Associated with Radiographic Progression Independently of Clinical Response
- Abstract Number: 1396
Persistence of Tocilizumab Therapy Among Patients with Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
- Abstract Number: 1505
Persistence with Etanercept in Patients with Ankylosing Spondylitis or Psoriatic Arthritis in Germany: A Real-World Analysis
- Abstract Number: 1602
Persistency in Platelet C4d and Thrombosis Risk Score Associate with Thrombosis in Systemic Lupus Erythematosus
- Abstract Number: 451
Persistent and Non-Articular Regional and Widespread Pain Are Common in Early Rheumatoid Arthritis, Impacting Remission Rates and Reflected in Patient Global Scores
- Abstract Number: 1572
Persistent Cognitive Impairment in Lupus Patients over 1 Year and Associated Factors
- Abstract Number: 1728
Persistent Disease Activity Is Associated with Avascular Necrosis Development in Juvenile Systemic Lupus Erythematosus
- Abstract Number: 114
Persistent Synovial Resident Memory T Cells Mediate Arthritis Flares
- Abstract Number: 2278
Perspectives About Contraception Among Reproductive-Aged Women with Rheumatic Diseases
- Abstract Number: 2277
Perspectives of Female Patients with Rheumatic Diseases Regarding Pregnancy Planning with Rheumatologists
- Abstract Number: 2860
Perturbation of the Human Gut Microbiome by Methotrexate Contributes to the Resolution of Inflammation and Autoimmune Disease
- Abstract Number: 2671
PET/CT Vascular Findings at Baseline and Six Months in Patients with Newly Diagnosed Giant Cell Arteritis
- Abstract Number: 993
pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Rheumatoid Arthritis
- Abstract Number: 2058
Pharmacoepidemiology of Gout Treatment in Office-based Outpatient Care from 2009- 2016
- Abstract Number: 1694
Pharmacogenetics and Pharmacodynamics of Response to Apremilast in a Phase 3 Clinical Study in Subjects with Active Behçet’s Disease
- Abstract Number: 2565
Pharmacokinetics and Exposure-response of Intravenous Belimumab in Children with Systemic Lupus Erythematosus
- Abstract Number: 2668
Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination with Prednisone Tapering in Patients with Giant Cell Arteritis: 3-Year Results from a Randomized Controlled Phase 3 Trial
- Abstract Number: 2541
Pharmacokinetics of Hydroxychloroquine in Systemic Lupus Erythematosus Patients with Renal Impairment
- Abstract Number: 2580
Pharmacotherapies Targeting Type 2 SLE Symptoms
- Abstract Number: 1217
Phase 2 Dose-ranging Study of SEL-212 in Symptomatic Gout Patients: Selection of Doses for Further Clinical Development
- Abstract Number: 530
Phase I Evaluation of the PDE4 Inhibitor LY2775240: Head to Head Comparison with Apremilast Using an Ex Vivo Pharmacodynamic Assay
- Abstract Number: 48
Phenotype-based Clustering Along with Analysis of Molecular Profile Might Help to Define Precise CV-risk Profiles in RA Patients
- Abstract Number: 2259
Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group
- Abstract Number: 1845
Physical Inactivity Is a Risk Factor for Incident Depression in Systemic Lupus Erythematosus
- Abstract Number: 954
Physical Therapy and Opioid Use in Knee Osteoarthritis
- Abstract Number: 1128
Physician-Patient Interaction and Medication Adherence in Lupus Nephritis
- Abstract Number: 1061
PI3K-Akt Pathway Plays a Crucial Role in Production of Collagen in Fli1 Deficient Condition and Its Inhibitor Has the Therapeutic Potential in Treating Fibrosis
- Abstract Number: 1216
Pilot, Randomized, Double-Blinded, Placebo Controlled Efficacy AndSafety Study of a Transdermal Alkalinizing and Pain Relieving Treatment ForAcute Gout Flare
- Abstract Number: 2563
PK/PD, Safety and Exploratory Efficacy of Subcutaneous Anifrolumab in SLE: A Phase-II Study in Interferon Type I High Patients with Active Skin Disease
- Abstract Number: 1617
Platelet Bound Complement Split Product (PC4d) May Be a Marker of Platelet Activation and Cardiovascular Events in Systemic Lupus Erythematosus
- Abstract Number: 979
Platelet Derived Growth Factor Receptor Alpha (PDGFRα) Blockade Inhibits Arthritis in Mice
- Abstract Number: 2790
Platelet Mediates Neutrophil Extracellular Traps Formation via TLR Signaling in ANCA-associated Vasculitis
- Abstract Number: 1960
Pleiotropy of Genetic Predisposition to Rheumatoid Arthritis Increases the Risk for Autoimmune Disease
- Abstract Number: 1959
Pleiotropy of Systemic Lupus Erythematosus (SLE) Risk Alleles: Association with Increased Risk for Type 1 Diabetes (T1D) Complications Through a PTPN22 Polymorphism
- Abstract Number: 1471
Polyautoimmunity and Major Organ Involvement Prevalence in Sjögren´s Syndrome: Thyroid, Liver, Lung and Kidney as Targets. a Single Center Cross Sectional Study
- Abstract Number: 1945
Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients
- Abstract Number: 118
Polymorphonuclear Neutrophils and Regulatory T Lymphocytes (Treg) Cooperate to Sustain Treg Activity but This Interaction Is Altered in Rheumatoid Arthritis Patients
- Abstract Number: 759
Polymyalgia Rheumatica Patients with and Without Elevated Baseline Acute Phase Reactants: Distinct Subgroups of Polymyalgia Rheumatica?
- Abstract Number: 742
Polymyalgia Rheumatica: New Therapeutic Strategy Based on Low Dose Metrotexate Plus Local Infiltration with Corticosteroids
- Abstract Number: 761
Polymyalgia Rheumatica: Winter Is Coming
- Abstract Number: 2245
Polymyositis (PM) and Dermatomyositis (DM) Symptom Flares and Associated Impact from the Patient Perspective
- Abstract Number: 2566
Polypharmacy and Potentially Inappropriate Medication Use in Young versus Older Adults with SLE
- Abstract Number: 1329
Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
- Abstract Number: 436
Poor Concordance Between Remission Judged by Physicians and a Patient-Acceptable Symptom State in Psoriatic Arthritis
- Abstract Number: 1569
Poor Long-term Renal Outcome in Systemic Lupus Erythematosus Without Abnormal Urinalysis: A Possible Link with Silent Lupus Nephritis
- Abstract Number: 1716
Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study
- Abstract Number: 1343
Pop a Pill or Give Myself a Shot? Patient Perspectives of Disease-modifying Anti-rheumatic Drug (DMARD) Choice for Rheumatoid Arthritis (RA)
- Abstract Number: 2077
Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia and the Fallacy of the Variance Explained
- Abstract Number: 2549
Population Pharmacokinetics of Atacicept in Systemic Lupus Erythematosus (SLE) – an Analysis of Three Clinical Trials
- Abstract Number: 1463
Positive Rate of Small Intestinal Bacterial Overgrowth Test (SIBO) Was Significant Correlations to Disease Activity of Primary Sjogren’s Syndrome (pSS)
- Abstract Number: 1411
Positivity of Anti-Ro/SSA Antibody Confer Poor Response and Persistence with Abatacept Therapy
- Abstract Number: 2261
Post Traumatic Stress Disorder in Patients with Rheumatoid Arthritis
- Abstract Number: 2372
Post-Approval Comparative Safety Study of Tofacitinib and Biologic DMARDs: Five‑Year Results from a US-based Rheumatoid Arthritis Registry
- Abstract Number: 1346
Post-Traumatic Stress Disorder, Depression, Anxiety and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
- Abstract Number: 73
Potent Anti-neutrophil Properties of the Natural Compound 6-Gingerol in Models of Lupus and Antiphospholipid Syndrome
- Abstract Number: 1774
Potential Involvement of OX40 Expressing Tfh Cells on Regulation of Autoantibody Sialylation in Experimental and Rheumatoid Arthritis
- Abstract Number: 649
Potentially Reversible Associations with Fatigue in SLE Patients – Results from a Single-centre Study
- Abstract Number: 1147
Poverty and Systemic Lupus International Collaborating Clinics Damage Index (SDI) Are Significant Risk Factors for Hospitalization in SLE Patients
- Abstract Number: 1198
Practice Based Education Program to Increase Vaccination Rate in Patients on Immunotherapeutic Agents
- Abstract Number: 368
Practice Patterns in Bone Health and Vitamin D Management in Sarcoidosis: A Survey of Physicians Who Manage Sarcoidosis
- Abstract Number: 1747
Practice Variations in Treatment of Pediatric Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (AAV) with Renal Disease
- Abstract Number: 1445
Pre-Biologic Use of Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis in the United States
- Abstract Number: 495
Pre-Rheumatoid Arthritis Diagnosis Prevalence of Commercial CCP Antibody Positivity Increases over Time with Strong Agreement Between Commercial Assays and Positivity Is Predicative of Developing Rheumatoid Arthritis Within 3 Years
- Abstract Number: 314
Pre-treatment Screening for Hepatitis B and C Among Users of Biologics or New Synthetic Disease Modifying Drugs: An Analysis Using RISE Data
- Abstract Number: 1983
Preclinical Evaluation of Targeting TGF-beta Signaling and Senescence in ex Vivo Models of Human Knee and Spine Osteoarthritis
- Abstract Number: 1084
Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice – Results from the EuroSpA Collaboration
- Abstract Number: 194
Predicting Remission in Rheumatoid Arthritis: External Validation for Tocilizumab Monotherapy Using Corrona Real World Data
- Abstract Number: 1519
Predicting Response to Biologic Therapy in Patients with Axial Spondyloarthritis (axSpA)
- Abstract Number: 2499
Predicting Risk of Developing Psoriatic Arthritis (PsA) in Siblings of Patients with Psoriatic Arthritis
- Abstract Number: 466
Predicting Risk of Radiographic Progression for Patients with Rheumatoid Arthritis
- Abstract Number: 1390
Prediction of Clinical Response to Abatacept in Rheumatoid Arthritis Patients Through the Determination of Anti-Carbamylated Proteins Antibodies Levels
- Abstract Number: 2390
Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission
- Abstract Number: 2335
Prediction of Myocardial Fibrosis in Rheumatoid Arthritis Assessed by Cardiac Magnetic Resonance Imaging Using Artificial Neural Networks Models
- Abstract Number: 1610
Prediction of Organ Damage Accrual in Systemic Lupus Erythematosus Using a Frailty Index
- Abstract Number: 2844
Predictive Factors for Mortality in Anti-melanoma-associated Gene 5 Antibody-associated Interstitial Lung Disease
- Abstract Number: 2912
Predictive Factors for Treatment Related Mortality and Event-Free Survival After Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Results of a Long Term Follow-up Multi-centre Study
- Abstract Number: 1300
Predictor of Placebo Response in Hand Osteoarthritis: A Post Hoc Analysis of Two Randomized Controlled Trials
- Abstract Number: 2625
Predictors of Advanced Chronic Kidney Disease in Patients with ANCA Vasculitis and Renal Involvement
- Abstract Number: 2491
Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice– Results from the EuroSpA Collaboration
- Abstract Number: 1715
Predictors of Gastrointestinal and Renal Involvement in Adult IgA Vasculitis
- Abstract Number: 2719
Predictors of Health Care Transition Practices Among North American Pediatric Rheumatology Providers
- Abstract Number: 1137
Predictors of Health-Related Quality of Life in Patients with Musculoskeletal Diseases: A Longitudinal Analysis from an Electronic Health Record Database
- Abstract Number: 2794
Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project
- Abstract Number: 766
Predictors of Long-term Therapy with Glucocorticoid in Polymyalgia Rheumatica
- Abstract Number: 1843
Predictors of Mortality Among Black Women with Systemic Lupus Erythematosus: The Black Women’s Experiences Living with Lupus (BeWELL) Study
- Abstract Number: 2650
Predictors of Relapse in Giant Cell Arteritis: Data from an International Collaboration
- Abstract Number: 651
Predictors of Renal Damage in Systemic Lupus Erythematosus Patients from Latin America
- Abstract Number: 2787
Predictors of Renal Involvement in ANCA-Associated Vasculitis
- Abstract Number: 1430
Predictors of Response to Etanercept-Methotrexate Treatment: Post-hoc Analysis of a Randomized, Open-label Study in Latin American Patients with Rheumatoid Arthritis
- Abstract Number: 785
Predictors of Response to Tumour Necrosis Factor – α Inhibitors (TNFi) in Juvenile Idiopathic Arthritis (JIA): A Single-center Experience
- Abstract Number: 1544
Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry
- Abstract Number: 1418
Predictors of Response, Adverse Events and Treatment Retention in RA Patients Treated with Either Subcutaneous- or Intravenous- Golimumab in a Prospective, Observational Registry
- Abstract Number: 2458
Predictors of Structural Progression in Psoriatic Arthritis: Clinical versus Systemic Inflammation
- Abstract Number: 934
Predictors of Survival of Secukinumab Treatment in a Multicenter Cohort of 556 Spondylarthritis
- Abstract Number: 2914
Predictors to Develop Definite Systemic Sclerosis (SSc): Results from an International Multicentre Study on Very Early DiagnOsis of Systemic Sclerosis (VEDOSS)
- Abstract Number: 2140
Preexisting Autoimmune Disease and Rheumatic Immune-Related Adverse Events Associated with Cancer Immunotherapy: A Case Series from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
- Abstract Number: 2268
Preferences and Insights for Rheumatoid Arthritis Clinical Prevention Trial Participation
- Abstract Number: 141
Pregnancy in Antiphospholipid Syndrome: Outcomes and Risk Factors – Data from a Portuguese Multidisclinary Unit
- Abstract Number: 2293
Pregnancy in Patients with Systemic Lupus Erythematosus After Cyclophosphamide Therapy
- Abstract Number: 2279
Pregnancy in Rheumatoid Arthritis: Continue, Reduce or Stop TNF Inhibitors? A Prospective Observational Study
- Abstract Number: 751
Pregnancy Outcome in Patients with Takayasu Arteritis: The Results of Turkish Takayasu Study Group
- Abstract Number: 2288
Pregnancy Outcomes in Women Exposed to Golimumab
- Abstract Number: 2775
Pregnancy Rates and Outcomes in Early Axial Spondyloarthritis: Analysis of the DESIR Cohort
- Abstract Number: 801
Preliminary Analysis of Hearing Loss in a Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Cohort Followed over a Mean of 10 Years: Normal Hearing at Baseline and Early Treatment with Anakinra Area Associated with Maintenance of Normal Hearing
- Abstract Number: 1908
Preliminary Identification of Arthritis-Associated Microbiota in Experimental Spondyloarthritis
- Abstract Number: 390
Preliminary Response to Janus Kinase (JAK) Inhibition with Baricitinib in Refractory Juvenile Dermatomyositis
- Abstract Number: 2264
Prescribing Exercise: Facilitators and Barriers to the Successful Implementation of Physical Activity Guidelines in Inflammatory Arthritis
- Abstract Number: 760
Prescribing Methotrexate in Polymyalgia Rheumatica: A Missed Opportunity?
- Abstract Number: 2553
Prescription Opioid Use and Osteoporotic Fractures in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
- Abstract Number: 1579
Presence of Antiphospholipid Antibodies in Patients with SLE and Venous Thromboembolic Events of African American and Caucasian Race
- Abstract Number: 2002
Presence of the MerTK Receptor on Human Synovial Tissue Macrophages Lowers Inflammatory Cytokine Production and Activation of the MerTK+CD206+ Subpopulation Limits the Inflammatory Response of Synovial Fibroblasts
- Abstract Number: 2673
Presentation and Management of Giant Cell Arteritis in a Real-World Setting (Artemis Study)
- Abstract Number: 327
Presentation Order Bias in Rheumatology Journals: A Content Analysis
- Abstract Number: 2597
Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis
- Abstract Number: 1576
Prevalence and Outcome of Thrombocytopenia in Systemic Lupus Erythematosus – Single Centre Cohort Analysis
- Abstract Number: 384
Prevalence and Predictors of Fibrosis in Rheumatological Patients on Therapy and Risk Factors for Chronic Liver Disease
- Abstract Number: 2583
Prevalence and Risk Factors of Herpes Zoster Reactivation in Patients with Biopsy Proven Lupus Nephritis Undergoing Immunosuppressive Therapies
- Abstract Number: 2398
Prevalence of Anxiety and Depression in a Cohort of Patients with Rheumatic Diseases on Biological Infusions
- Abstract Number: 903
Prevalence of Atopic Features in Classic Autoinflammatory Diseases
- Abstract Number: 1120
Prevalence of Burnout in Rheumatology Professionals
- Abstract Number: 1589
Prevalence of Cognitive Impairment in an Inception Lupus Cohort as Assessed by a Comprehensive Neuropsychological Battery
- Abstract Number: 2087
Prevalence of Corticosteroid Use in Incidental Vertebral or Hip Fractures
- Abstract Number: 1103
Prevalence of Diagnosed Systemic Lupus Erythematosus (SLE), Patient Healthcare Utilization and Characteristics by Major Health Insurance Types in the US
- Abstract Number: 2475
Prevalence of Disease Domain Presentations Among Patients with Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- Abstract Number: 296
Prevalence of Elbow Arthritis in Patients with Rheumatoid Arthritis: A Prospective Ultrasound Study
- Abstract Number: 410
Prevalence of Malignancy in Myositis Patients with Anti-aminoacyl-tRNA Synthetase Antibodies: A Single Center Retrospective Study and Literature Review
- Abstract Number: 1601
Prevalence of Peripheral Neuropathy and Its Electrophysiological Types in Patients with Systemic Lupus Erythematosus
- Abstract Number: 2163
Prevalence of Postoperative Anemia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Undergoing Total Knee Arthroplasty: A Study of National Inpatient Sample 2010-2014
- Abstract Number: 608
Prevalence of Radiographic Entheseal Lesions at the Hip and Pelvic Region in Patients with Ankylosing Spondylitis versus Controls
- Abstract Number: 181
Prevalence of Renal Impairment in a US Rheumatoid Arthritis Population
- Abstract Number: 1174
Prevalence of Subclinical Sacroiliitis in Young Patients with Inflammatory Bowel Disease Revealed by Entero-MRI
- Abstract Number: 1311
Prevalence of Symptomatic Axial Osteoarthritis and Poliarticular Phenotypes in Spain: EPISER 2016 Study
- Abstract Number: 2886
Prevalence of Systemic Lupus Erythematosus in the United States: Preliminary Estimates from a Meta-Analysis of the Centers for Disease Control and Prevention Lupus Registries
- Abstract Number: 2072
Prevalence of Thyroid Dysfunction with Therapeutic Indication in Patients with Rheumatological Diseases
- Abstract Number: 2306
Prevalent and Incident Multimorbidity in Rheumatoid Arthritis: A Population-Based Cohort Study
- Abstract Number: 1549
Primary 1-Year Data of Ixekizumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Patients with Radiographic Axial Spondyloarthritis Including Data in Patients Rerandomized from Adalimumab to Ixekizumab
- Abstract Number: 352
Primary Hyperparathyroidism Is Associated with a Higher Level of Serum Uric Acid: A Systematic Review and Meta-analysis
- Abstract Number: 1472
Primary Sjögren’s Syndrome and Development of Another Connective Tissue Disease During Follow-up
- Abstract Number: 454
Principal Component Analysis Identifies Unique Sub-Populations in Rheumatoid Arthritis Using a Combination of Serological Biomarkers: A Cross Sectional Study
- Abstract Number: 2149
Principal Components Analysis as a Tool to Identify Lesional Skin Patterns in Cutaneous Lupus Erythematosus
- Abstract Number: 703
Prior Knowledge Feature Reduction Improves Performance in a Machine Learning Model of Systemic Lupus Erythematosus Flare Status Using Serum Proteomics
- Abstract Number: 1085
Probiotic Use and Psoriatic Arthritis Disease Activity
- Abstract Number: 481
Production of IL17A in Synovial Tissue Correlates with MRI RAMRIS Scores in ACPA Positive Early Rheumatoid Arthritis
- Abstract Number: 1056
Profibrotic Macrophage Activation in Systemic Sclerosis Is Dependent on the Mechanosensing MRTF-A Pathway
- Abstract Number: 2301
Profile of Renal Function in Patient Suffering from Rheumatoid Arthritis
- Abstract Number: 2705
Profiling Behavioral and Psychological Symptoms in Children with Spondyloarthritis and Polyarthritis
- Abstract Number: 2558
Profiling of Gene Expression, Immune Cell Subtypes, and Circulating Protein Biomarkers in Systemic Lupus Erythematosus Patients Treated with the Selective Immunoproteasome Inhibitor, KZR-616
- Abstract Number: 2289
Progesterone Decreases Gut Permeability Through Upregulating Occludin Expression in Primary Human Gut Tissues and Caco-2 Cells
- Abstract Number: 465
Prognostic Factors and Clinical Outcome Modifiers in Patients with Rheumatoid Arthritis: A Review
- Abstract Number: 373
Prognostic Factors and Long-term Outcomes in Cardiac Sarcoidosis
- Abstract Number: 2326
Prognostic Markers for Preclinical Cardiovascular Disease in Rheumatoid Arthritis and Correlation with Disease Activity
- Abstract Number: 2587
Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis
- Abstract Number: 1583
Prognostic Value of Urinary Biomarkers for the Developing of End Stage Renal Disease in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1624
Progression and Factors Associated with Damage Accrual in a SLE Inception Cohort of Hispanic Patients
- Abstract Number: 2823
Progression to Inflammatory Arthritis After Screening Autoantibody Positive in a Non-Clinical Setting
- Abstract Number: 300
Proliferative Globular Synovitis, an Ultrasound Pattern Associated with Seropositive Rheumatoid Arthritis
- Abstract Number: 2454
PROMIS Profile29 Differentiates Active Disease from Treat-to-Target State in Psoriatic Arthritis
- Abstract Number: 1040
Proposition of a Novel Animal Model of Systemic Sclerosis Induced by Type V Collagen in C57BL/6 Mice Reproducing Fibrosis, Vasculopathy and Autoimmunity
- Abstract Number: 2882
Prospective Demonstration That Attainment of the Lupus Low Disease Activity State Is Associated with Improved Health Related Quality of Life
- Abstract Number: 2567
Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates
- Abstract Number: 596
Prostaglandin Receptor EP4 Drives Pathogenic Th17 Cell Development in Ankylosing Spondylitis and Is a New Marker of Disease Activity
- Abstract Number: 1973
Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies
- Abstract Number: 2405
Protein Biomarkers Predicting the Response to IFX+MTX+LEF Treatment in Patients with Rheumatoid Arthritis
- Abstract Number: 2004
Protein Profiling and Network Enrichment Analysis in Individuals Before and After the Onset of Rheumatoid Arthritis
- Abstract Number: 1055
Proteomic and Transcriptomic Analysis of Human Eosinophilic Fasciitis Fibroblasts
- Abstract Number: 2557
Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics and Outcomes – Case Control Study
- Abstract Number: 2825
Provider Variability in Glucocorticoid Prescribing for Patients with Rheumatoid Arthritis and Impact on Chronic Glucocorticoid Use
- Abstract Number: 1816
Psoriasis Associated with Anti-Tumor Necrosis Factor-Alpha Therapies in Children with Inflammatory Bowel Disease, Juvenile Idiopathic Arthritis, and Chronic Noninfectious Osteomyelitis
- Abstract Number: 2509
Psoriasis Impact on Patient-Reported Outcomes in Psoriatic Arthritis in a Real-World Setting: Results from the APOPSIS Study
- Abstract Number: 1086
Psoriatic Arthritis – Epidemiology, Incidence Rate in Psoriasis Patients, Comorbidity Profiles and Risk Factor Analysis
- Abstract Number: 1212
Psychological Profile in Patients with Rheumatic Diseases in China: A Study of HADS Self-assessment with Smart System of Disease Management (SSDM)
- Abstract Number: 1203
Psychometric Properities of the Patient Related Outcome Measure FACIT-Fatigue in Rheumatic Arthritis and Psoriatic Arthritis: A Literature Review
- Abstract Number: 431
Psychometric Properties of the Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS®) Item Banks in a Dutch Clinical Sample of Children with Juvenile Idiopathic Arthritis
- Abstract Number: 1461
Pulmonary Cysts: Very Common Finding on Computed Tomography of the Chest of Asymptomatic Patients with Primary Sjögren’s Syndrome
- Abstract Number: 2006
Pyruvate Kinase M2 May Contribute to the Inflammation and Joint Destruction in Rheumatoid Arthritis
2019 ACR/ARP Annual Meeting
November 8-13, 2019. Atlanta, GA.